Skip to main content
Erschienen in: Neurological Sciences 1/2020

16.08.2019 | Original Article

Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study

verfasst von: Chen Zhu, Guangzong Li, Zhiyu Lv, Jing Li, Xiangming Wang, Jie Kang, Cheng Zhan

Erschienen in: Neurological Sciences | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Post-stroke cognitive impairment (PSCI) is a clinical condition arising from stroke and causes significant changes to memory, thinking, and behavior. Trimethylamine-N-oxide (TMAO), the metabolite produced by gut microbiota, has mechanistic relevance to atherosclerotic diseases. This study aimed to investigate whether an association existed between elevated plasma TMAO levels and PSCI.

Methods

Consecutive patients with acute ischemic stroke were prospectively enrolled during Jan. 2017 to Dec. 2017. TMAO concentration was measured within 24 h after admission. PSCI was assessed using the Mini-Mental State Examination (MMSE) score after 1 year and defined as MMSE score ≤ 26. Binary logistic regression analysis was used to determine the contribution of TMAO level in the prediction of PSCI.

Results

Of the 256 patients studied (age, 67.1 ± 11.0 years; male, 54.3%), 86 (33.6%) patients were diagnosed as PSCI. The mean TMAO level was 5.6 ± 2.4 μM, with quartile level as follows: < 3.9 μM (first quartile), 3.9–5.1 μM (second quartile), 5.2–7.4 μM (third quartile), and > 7.4 μM (fourth quartile). After controlling for potential confounders, multivariable logistic analysis showed that higher level of plasma TMAO was an independent predictor for cognitive impairment in post-stroke patients (the quartile 1 was used as reference, the quartile 4 odds ratio, 3.304; 95% confidence intervals, 1.335–8.178; P = 0.010).

Conclusions

This study demonstrated that increasing plasma level of TMAO may be associated with PSCI.
Literatur
14.
Zurück zum Zitat Li D, Ke Y, Zhan R, Liu C, Zhao M, Zeng A, Shi X, Ji L, Cheng S, Pan B, Zheng L, Hong H (2018) Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell 2018:e12768. https://doi.org/10.1111/acel.12768CrossRefPubMedPubMedCentral Li D, Ke Y, Zhan R, Liu C, Zhao M, Zeng A, Shi X, Ji L, Cheng S, Pan B, Zheng L, Hong H (2018) Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell 2018:e12768. https://​doi.​org/​10.​1111/​acel.​12768CrossRefPubMedPubMedCentral
Metadaten
Titel
Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study
verfasst von
Chen Zhu
Guangzong Li
Zhiyu Lv
Jing Li
Xiangming Wang
Jie Kang
Cheng Zhan
Publikationsdatum
16.08.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 1/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04040-w

Weitere Artikel der Ausgabe 1/2020

Neurological Sciences 1/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.